2019 Immuno-Oncology 360˚

IO360˚ is a strategic-level conference where pharmaceutical and biotechnology industry professionals present alongside academia and investors and hold partnering meetings, so as a community we can drive faster advancements to eradicate cancer.

CRI members receive a 20% off registration with the discount code CRI20. 

Guided by Dr. Andrew Baum (Citi), Dr. Axel Hoos (GSK) and Dr. James Gulley (NCI), the 5th annual Immuno-Oncology 360° program includes more than 80 speakers and over 60 talks. 

Immuno-Oncology 360° provides 10 plenary sessions over the course of 3 days addressing:

  • Discovery / Preclinical Science
  • Translational Science & Biomarkers
  • Clinical Data Developments
  • Clinical Operations
  • Imaging Aspects
  • Cell Therapy
  • Emerging Technologies
  • Business Aspects
  • Financial & Commercial Implications
  • Trends in the Field

Follow the hastag #io360nyc

Join our email list for updates on cancer immunotherapy research, events, and opportunities to get involved with the Cancer Research Institute. Sign up below and be a force for change in the fight against cancer.

Join CRI in Shaping the Future of Immunotherapy

Support the pioneering work of CRI in advancing immunotherapy.

Father and son